603259 药明康德
2021/03 - 三个月2020/122019/122018/122017/12

盈利能力分析
净资产收益率 ROE (%)4.42511.88710.59718.81420.603
总资产报酬率 ROA (%)3.1617.8397.14612.82710.592
投入资产回报率 ROIC (%)3.6019.0678.42416.10416.324

边际利润分析
销售毛利率 (%)37.09937.99238.95139.45141.833
营业利润率 (%)34.29020.49818.18626.88618.809
息税前利润/营业总收入 (%)34.91123.52018.34127.43022.885
净利润/营业总收入 (%)30.44418.06014.84924.27516.699

收益指标分析
经营活动净收益/利润总额(%)56.26477.377104.85969.85083.917
价值变动净收益/利润总额(%)41.01619.544-9.05926.5832.541
营业外收支净额/利润总额(%)-0.097-0.597-0.169-0.1508.290

偿债能力分析
流动比率 (X)2.6052.9111.9093.1381.183
速动比率 (X)2.2322.5721.6462.8851.026
资产负债率 (%)26.91829.32040.45819.86146.441
带息债务/全部投入资本 (%)9.39110.26319.9264.19117.963
股东权益/带息债务 (%)877.498782.145350.1392,195.950398.679
股东权益/负债合计 (%)269.730239.406146.349392.895108.557
利息保障倍数 (X)53.3787.48298.53346.9149.634

营运能力分析
应收账款周转天数 (天)68.52371.86068.95667.24568.868
存货周转天数 (天)83.39677.74161.73051.93249.344